Journal: PLoS Pathogens
Article Title: GAS6 signaling tempers Th17 development in patients with multiple sclerosis and helminth infection
doi: 10.1371/journal.ppat.1009176
Figure Lengend Snippet: A ) Representative dot plots showing the three main sub-populations of mononuclear cells based on the expression of CD11b, CD4, and CD1c. TYRO3, AXL, and MERTK expression were evaluated in circulating monocytes (CD11b high CD4 mid ) and DCs (CD1c high CD11b low ) of patients with MS, patients with HIMS, and healthy controls by flow cytometry. B-G ) The percentage of TYRO3-positive as well as the mean fluorescent intensity (MFI) of the receptor on monocytes ( B, C, and D ) and DCs ( E, F, and G ) are graphed. H, I, and J ) The percentage of AXL high as well as the MFI of the receptor on DCs are shown. K, L, and M ) The expression of MERTK on DCs is shown as both percentage and MFI. N, O, and P ) The percentage of circulating CD4 + T cell expressing GAS6 as well as its MFI are shown. Q, R, and S ) The percentage of circulating CD4 + T cell expressing PROS1 and its MFI are shown. Data is presented as a pool of independent samples included in the specific staining (Control N = 21–31; MS N = 10–27; and HIMS N = 11–16). One-way ANOVA with a Fisher post hoc test was performed to determine statistical significances, *p<0.05 **p≤0.01 ****p≤0.001. MS = multiple sclerosis, HIMS = helminth-infected multiple sclerosis.
Article Snippet: Rabbit anti-human TYRO3 (Novus Biological), biotin-conjugated goat anti-human AXL, and APC anti-human MERTK mAb IgG1 (R&D Systems) were used to evaluate TAM receptor expression after fixation and permeabilization (Cytofix/Cytoperm Kit, BD Bioscience, San Diego, CA, USA).
Techniques: Expressing, Flow Cytometry, Staining, Control, Infection